These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma. Murthy M; Azizan EA; Brown MJ; O'Shaughnessy KM J Hypertens; 2012 Sep; 30(9):1827-33. PubMed ID: 22743686 [TBL] [Abstract][Full Text] [Related]
4. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling. Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008 [TBL] [Abstract][Full Text] [Related]
5. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance. Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571 [TBL] [Abstract][Full Text] [Related]
6. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Azizan EA; Murthy M; Stowasser M; Gordon R; Kowalski B; Xu S; Brown MJ; O'Shaughnessy KM Hypertension; 2012 Mar; 59(3):587-91. PubMed ID: 22252394 [TBL] [Abstract][Full Text] [Related]
7. A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma. Lenzini L; Rossitto G; Maiolino G; Letizia C; Funder JW; Rossi GP J Clin Endocrinol Metab; 2015 Aug; 100(8):E1089-95. PubMed ID: 26066531 [TBL] [Abstract][Full Text] [Related]
8. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422 [TBL] [Abstract][Full Text] [Related]
9. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas. Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161 [TBL] [Abstract][Full Text] [Related]
13. Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas. Tauber P; Penton D; Stindl J; Humberg E; Tegtmeier I; Sterner C; Beuschlein F; Reincke M; Barhanin J; Bandulik S; Warth R Endocrinology; 2014 Apr; 155(4):1353-62. PubMed ID: 24506072 [TBL] [Abstract][Full Text] [Related]
14. Genetics of Aldosterone-Producing Adenoma in Korean Patients. Hong AR; Kim JH; Song YS; Lee KE; Seo SH; Seong MW; Shin CS; Kim SW; Kim SY PLoS One; 2016; 11(1):e0147590. PubMed ID: 26807823 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients. Wang B; Li X; Zhang X; Ma X; Chen L; Zhang Y; Lyu X; Tang Y; Huang Q; Gao Y; Fan Y; Ouyang J Medicine (Baltimore); 2015 Apr; 94(16):e708. PubMed ID: 25906099 [TBL] [Abstract][Full Text] [Related]
16. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452 [TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling. Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392 [TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas. Murakami M; Yoshimoto T; Nakabayashi K; Nakano Y; Fukaishi T; Tsuchiya K; Minami I; Bouchi R; Okamura K; Fujii Y; Hashimoto K; Hata KI; Kihara K; Ogawa Y Endocr Relat Cancer; 2017 Oct; 24(10):531-541. PubMed ID: 28747387 [TBL] [Abstract][Full Text] [Related]
19. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126 [TBL] [Abstract][Full Text] [Related]
20. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5. Scholl UI; Lifton RP Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]